# OnCo record idea-ai-her2-low-scoring (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-ai-her2-low-scoring/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-ai-her2-low-scoring" ;
  schema:name "AI quantification of HER2-low and HER2-ultralow"@en ;
  schema:description "Pathologists disagree about faint HER2 staining, yet that decision unlocks Enhertu. Let a validated algorithm do the counting."@en ;
  schema:url <https://onco.cc/ideas/idea-ai-her2-low-scoring/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2203690> ;
  onco:related <https://onco.cc/pairings/her2-low-to-tdxd/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/digital-pathology-ai/>, <https://onco.cc/technologies/histopathology-ihc/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:terms <https://onco.cc/terms/her2-low/>, <https://onco.cc/terms/ihc/> ;
  onco:trials <https://onco.cc/trials/destiny-breast04/>, <https://onco.cc/trials/destiny-breast06/>, <https://onco.cc/trials/nct05950945/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-trastuzumab-deruxtecan-breast-hr-positive-ann-oncol-2026/>, <https://onco.cc/key-papers/paper-trastuzumab-deruxtecan-tnbc-esmo-open-2021/>, <https://onco.cc/key-papers/paper-trastuzumab-deruxtecan-tnbc-expert-opin-biol-ther-2021/> .